Valuation: Vidipha Central Pharmaceutical

Market Cap 704B 27.27M 24.47M 22.6M 20.49M 38.3M 2.59B 38.77M 271M 108M 1.36B 102M 100M 4.31B P/E 2024
11.4x
P/E 2025 20.1x
Enterprise Value 469B 18.17M 16.31M 15.06M 13.66M 25.53M 1.73B 25.84M 181M 71.71M 905M 68.22M 66.76M 2.87B EV / Sales 2024
0.81x
EV / Sales 2025 1.06x
Free-Float
7.95%
Yield 2024
6.76%
Yield 2025 -
07-21 Vidipha Central Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
06-08 Vidipha Central Pharmaceutical Joint Stock Company Proposes No Dividend for 2025 CI
06-08 Vidipha Central Pharmaceutical Joint Stock Company Provides Earnings Guidance for the Year 2026 CI
04-19 Vidipha Central Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
01-20 Vidipha Central Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
01-10 Vidipha Central Pharmaceutical Joint Stock Company Announces Board Changes CI
12-31 Vidipha Central Pharmaceutical Joint Stock Company Announces the Resignation of Hoang Van Hoa as Member of the Board of Directors on December 30, 2025 CI
12-31 Vidipha Central Pharmaceutical Joint Stock Company Announces Resignation of Hoang Van Hoa as A Member of the Board of Directors, Effective from December 30, 2025 CI
02/10/25 Vidipha Central Pharmaceutical Joint Stock Company Announces Change in the Certificate of Business Registration CI
22/04/25 Vidipha Central Pharmaceutical Joint Stock Company Approves Board Changes CI
22/04/25 Vidipha Central Pharmaceutical Joint Stock Company Provides Earnings Guidance for the Year 2025 CI
22/04/25 Vidipha Central Pharmaceutical Joint Stock Company Approves Dividend Plan for 2025 CI
04/03/25 Vidipha Central Pharmaceutical Joint Stock Company Announces Second Dividend Payment for 2024, Payable on May 15, 2025 CI
1 day+6.33%
1 week+2.90%
Current month-21.91%
1 month-5.34%
3 months-20.25%
6 months-39.81%
Current year-45.00%
1 week 29,600
Extreme 29600
31,950
1 month 29,600
Extreme 29600
40,850
Current year 24,000
Extreme 24000
60,500
1 year 24,000
Extreme 24000
60,500
3 years 24,000
Extreme 24000
60,500
5 years 24,000
Extreme 24000
60,500
10 years 22,875
Extreme 22875
60,500
Manager TitleAgeSince
Chief Executive Officer 60 01/06/2011
Director of Finance/CFO 49 01/10/2024
Comptroller/Controller/Auditor 50 01/09/2024
Director TitleAgeSince
Chairman 78 01/04/2014
Director/Board Member 49 01/04/2012
Director/Board Member 60 24/04/2021
Change 5-day change 1-year change 3-year change Capi.($)
+6.33%+2.90%-39.24%+0.74% 27.27M
+0.22%-0.14%+55.12%+128.82% 1,143B
+0.91%+3.61%+41.21%+84.57% 647B
-0.12%-0.93%+25.59%+106.14% 506B
-0.94%+0.99%+51.63%+64.07% 384B
+0.86%-4.37%+61.16%+37.93% 350B
+0.76%+2.41%+31.43%+53.54% 293B
-0.51%+1.41%+3.11%+25.19% 265B
+0.75%+2.05%+53.85%+71.25% 242B
+0.25%+1.64%+32.05%+107.62% 197B
Average +0.69%+1.04%+31.59%+67.99% 402.76B
Weighted average by Cap. -0.00%+0.71%+43.02%+87.99%

Financials

2024 2025
Net sales 934B 36.17M 32.47M 29.98M 27.18M 50.81M 3.44B 51.43M 359M 143M 1.8B 136M 133M 5.71B 986B 38.15M 34.24M 31.62M 28.67M 53.59M 3.62B 54.25M 379M 151M 1.9B 143M 140M 6.02B
Net income 71.82B 2.78M 2.5M 2.3M 2.09M 3.91M 264M 3.95M 27.62M 10.97M 138M 10.44M 10.21M 439M 63.81B 2.47M 2.22M 2.05M 1.86M 3.47M 235M 3.51M 24.54M 9.75M 123M 9.27M 9.07M 390M
Net Debt -58.18B -2.25M -2.02M -1.87M -1.69M -3.16M -214M -3.2M -22.38M -8.89M -112M -8.45M -8.27M -356M -235B -9.1M -8.16M -7.54M -6.84M -12.78M -864M -12.93M -90.37M -35.89M -453M -34.14M -33.41M -1.44B
Projected Income Statement - Annual - Vidipha Central Pharmaceutical
Logo Vidipha Central Pharmaceutical
Vidipha Central Pharmaceutical Joint - Stock Company is a Vietnam-based company primarily engaged in the pharmaceuticals sector. The Company's leading business activity is the manufacture of pharmaceuticals in various forms, such as tablet, liquid, powder and ointment. The Company's products include antibiotics, anti-inflammatory drugs, vitamins, minerals, pain killers, antipyretics and antihistamines, among others.
Employees
469
Date Price Change Volume
27/10/26 ₫31,900.00 +6.33% 213
26/10/26 ₫30,000.00 0.00% 3,823
23/10/26 ₫30,000.00 +1.35% 1,000
22/10/26 ₫29,600.00 -4.67% 2,243
21/10/26 ₫31,050.00 +0.16% 1,324

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Vidipha Central Pharmaceutical